FDA
-
-
-
-
-
-
-
Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual Conference
-
-
-
-
-
-
-
Instil Bio Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Instil Bio Announces Appointment of Tim Moore as Chief Operating Officer
-
-
-
-
-
-
-
Instil Bio to Present Novel TIL Analytics at American Society of Gene and Cell Therapy (ASGCT)
-
-
-
-
-
-
-
Instil Bio Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Instil Bio Reports Second Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Instil Bio Presents Clinical Data in Metastatic Melanoma in a Late-Breaking e-Poster at the 2021 American Association for Cancer Research (AACR) Annual Meeting
-
322,096 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

